big pharma blocked this. they kept prescription drug prices high to increase their profits and extend patents on existing drugs to suppress fair competition instead of innovating playing games and pricing so they can charge whatever they can. but this is finally, finally, finally, we had enough votes by a matter of one to beat big pharma. well, we did it, [applause] we passed the inflation reduction act with no help from the other team, every single person on the other team in the congress voted against it, every single one. and we're in a situation here where the law finally gave medicare the power to negotiate lower prescription drug prices. and by the way, negotiating drug prices alongside other provisions of this law isn't just going to put more money back in the pockets of millions of americans across the country. it's also going to lower the federal deficit. [applause] what according to the congressional budget office, it will save the federal government $160 billion over the next 10 years because medic

biden: for years, big pharma blocked us. they kept prescription drug prices high to increase profits, extend patents to suppress competition instead of innovating. playing games with pricing so they could charge whatever they can. but this is finally, finally, finally been enough votes to be big pharma. amy: the negotiated prices will not take effect until 2026 and some drugs will remain exempted from further negotiations, including those which were approved by the fda less than nine years ago. in uganda, two men are facing what are believed to be the first charges of aggravated homosexuality after a draconian new anti-lgbtqia law was passed earlier this year, which also punishes consensual same-sex relations. the charges could lead to life in prison and even the death penalty. the law has been widely condemned by rights groups, the u.n., and other countries. earlier this month, the world bank said it is suspending new loans to uganda over the law. meanwhile, in nigeria, over five dozen people were arrested at a gay wedding

i think that's a huge mistake for anyone who owns pharma stocks now, big pharma is going all out here it was filed in different jurisdictions, merrick's case is in d.c., bristol myers in new jersey, they're all pursuing different strategies merck and bristol myers claim the drug pricing rules violate the first and fifth amendment. i don't think it's a free speech issue, but they have some arguments about how there's not a lot of talk about it the first amendment feels like a stretch, but the fifth amendment requires the government to pay just compensation, it's called a take it, and when it takes private property for public use, merck and bristol myers say they are being coerced into negotiating lower prices, they get hit with an excise task. from their perspective, they're basically being robbed by the government without fair compensation for some it might feel like a stretch, but i think they may get a win with a sympathetic judge. the big pharma lawsuit claims the ira prices violate the 8th amendment, cruel and unusual punishment, but it also prohibits excessive fines, the way the

big pharma. well, we did it. every other team in the congress voted against it. and we're in a situation where the law finally gave medicare the power to negotiate lower prescription drug prices. by the way, negotiating drug prices isn't just going to put more money in the pockets of millions of americans across the country. it's also going to lower the federal deficit. it will save the federal government $160 billion over the next ten years because medicare will be paying less for the prescription drugs they're making available to seniors. inflation reduction act is already making a huge difference. take insulin as referenced by steven. it costs that drug $10 to make. the guy who invented the drug, came up with it, didn't patent it because he wanted it available for everybody but drug companies are charging 30 times that $10 or more than that. now because of the inflation reduction act, seniors like steve are paying $35 a month instead of $400 a month. all three of the major insulin manufacturer

for years, big pharma blocked this. they kept prescription drug prices high to increase profits, extend patents on existing drugs instead of innovating. playing games with pricing so they could charge whatever they can. but this finally has enough votes by a matter of one, to beat big pharma. well, we did it. [ applause ] >> we passed the inflation reduction act with no help from the other team. every other person on the other team in the congress voted against it, every single one. we're in a situation that the law finally gave medicare the power to negotiate lower prescription drug prices. lowering drug prices isn't just going to put more money back in the pockets of millions of americans across the country, it's also going to lower the federal deficit. [ applause ] >> according to the congressional budget office it will save the government $160 billion over the next ten years because medicare will be paying less for prescription drugs they're making available to the seniors. inflation reduction act is already making

i have been fighting pharma on this since 1970. not a joke. this time we finally beat big pharma.icare has the power to negotiate prescription drug prices. the department of veterans affairs has had the power. that's not all. we have already spoken about insulin. by the way, the guy who invented insulin, he didn't patent it because he wanted it available for everyone. guess what, it costs $10 to make. everything including the packaging it can be $12.50. companies are charging 30 times that amount. we are paying as much as $400 a month for insulin. not just $35 a month. we are also capping total out-of-pocket expenses for seniors and medicare to $2000 a year for even expensive cancer drugs that can cost as much as $14,000 a year. combine all the costs of the drugs by 2025, they will never have to pay more than $2000. [applause] one in three seniors on medicare is going to save an average of $400 a year. seniors with the highest drug costs will save $2500 a year. pharma companies are still going to do very well. drug companies will raise prices faster than inflation. if they do that

the problem with that is that under the law we can get to purdue pharma.ividual family money that is behind that is much more difficult legally in most of our states. the other issue which is a policy issue is what we do with these mass torts that are no mass that they are existential lawsuits and to maximize the recovery for the the -- done you have to have some means of marshaling all these claims. and this is going to be an interest argument. >> and your argument is, correct me if i'm wrong, there are people in ohio and others aides who need help now, who need that money now. organizations that need to help people who are still suffering in this epidemic that continues to take thousands of lives per year, is that right? >> that's correct. and as the court of appeals says bankruptcy is a creature of compromiser. it a messy process of competing interest. >> we have seen preliminary data showing drug overdose deaths have leveled off but more than 100 thousand americans losing their lives and most of them i believe opioids. how is ohio working to alleviate

a massive settlement for purdue pharma is on hold this morning.deal that would protect members of the sackler family from more opioid-related lawsuits. purdue pharma made oxycontin and a lot of money for the sackler family. the drug brought in an estimate $35 billion for the company. using aggressive marketing tactics, millions of americans became adicked to the opioid. cheryl lost her two sons cory and sean. >> i've lost my children. i've lost two of my children. that is a life sentence in itself. >> reporter: such deaths led to an avalanche of lawsuits against the company and its owners. the crisis dramatized on hulu's "dope sick." purdue pharma filed for bankruptcy in to 19 under the terms of the bankruptcy, members of the sackler family will be shielded for future lawsuits in exchange for $6 billion that could be used to settle opioid related claims. but the justice department said the sacklers should not be able to use legal protections designed tor debtors illegal suppress and the solicitor general warning it would leave in place a road map

big pharma doesn't just get a blank check at your expension, the expense of the american people.y watch, health care is a right, not a privilege in this country. we're going keep standing up to big pharma, and we're not going to back down. [ cheers and applause ] >> this is part of what is technically called the inflation reduction act from the white house. seniors are supposed to save money, and interestingly, so should the government. there's an independent office, nonpartisan. that's not a biden administration source, and they do these estimates. they project that just going forward with this, standing up the big pharma, could save the feds over $3 billion a year and over $100 billion in ten years. straightforward. here is some of how republicans tried to stop this on the way. >> the american people don't want the government shut down, and they don't want obamacare. >> coming together to stop obamacare is the essence of pragmatism because it is self-evident this isn't working. >> their bipartisan bill fails to enact any bipartisan accountability for big pharma. >> this is a cl

>> god for pharma companies. did you live your life normally? >> okay,)r pharma companies.y, look, rma companies. did you live your life normally? >> okay, look, undoubtedly es. >> okay, look, undoubtedly without pharma companies, we were possibly dead were quite possibly all be dead by right? so there is no by now, right? so there is no doubt about that. there is doubt about that. but there is also massive, massive, massive corruption comes pharmaceuticals. >> it all. patrick. how >> stop it all. patrick. how would you stop this happening? >> well, i say that if >> well, i would say that if somebody has in position somebody has been in a position of a government that of power in a government that has able to or to has been able to procure or to help terms of the rollout of help in terms of the rollout of a particular product, i think it should be a prerequisite of being public official being a public health official that shouldn't then be able that you shouldn't then be able to into is essentially to go into what is essentially a glorified lobbying position . glorified lob

still ahead, the latest from pharma bro. remember martin shkreli?price of a life saving drug by 5,000% and sentenced to his for a multimillion dollar fraud scheme? he was released in prison in 2022, but he remains in twitter prison. calling out elon musk for his continued ban of the platform. charlie gasparino is breaking the story next. he has spoken to shkreli. he's going to reveal what's going on with that. closing bell, 4 minutes away. new session -- 14 minutes away. new session highs for the dow, up 299 points. the s&p up 66. up 301 for the dow. nasdaq, a big rally of 1.8% or 248 points. and volatility just keepses dropping, down 4%. no the fear on wall street, at least for the moment. it's at a 44-week low. ♪ -- 4-week low. ♪ ♪ i'm so glad we did this. i'm so glad we did this. i'm so glad we did this. i'm so... ...glad we did this. [kid plays drums] life is for living. let's partner for all of it. i'm so glad we did this. edward jones . . i may be known for my legendary football career, but truth is, i love a bunch of sports. the only trouble

it's really only because pharma got a sweetheart deal carve out, decades ago.at medicare has not been able to negotiate drug prices until the inflation reduction act. that's why today is so historic. this thing with health care advocates, many people who've been working in this field for decades have advocated, for it's finally coming to fruit. >> let me ask you a timeline question, as a veteran of the affordable care act battles, famously, the affordable care act was pulled very poorly. pulled very well before it started being debated, pulled poorly by the time is being passed. it continued to pull very poorly in the first year or two. and then they tried to repeal it twice, they couldn't do it. because a very popular, very popular now. partly, there's a bunch of reasons for that. partly, delayed implementation. so, people don't get to see what the law was, and the tangible status quo that was gonna produce. are you worried about the timeline here, where these new drug prices aren't going to hit people, i think, until after the election? they have a similar so

and what could it all mean for pharma stocks, ahead.watching "fast money," live from the nasdaq market site in times square. ll do for busin. introducing watsonx a platform designed to multiply output by tailoring ai to your needs. when you watsonx your business, you can build ai to help coders code faster, customer service respond quicker, and hr handle repetitive tasks in less time. let's create ai that transforms business with watsonx. ibm. let's create. you got this. let's go. gobble gobble. i've seen bigger legs on a turkey! rude. who are you? i'm an investor in a fund that helps advance innovative sports tech like this smart fitness mirror. i'm also mr. leg day...1989! anyone can become an agent of innovation with invesco qqq, a fund that gives you access to nasdaq-100 innovations. i go through a lot of pants. before investing carefully read and consider fund investment objectives, risks, charges, expenses and more in prospectus at invesco.com. all-day energy starts with clean hydration. lmnt. more electrolytes. zero sugar. you fe

a huge week ahead for big pharma, as the biden administration gets set to announce the first ten drugs selected for price negotiation analysts are expects treatments from pfizer, eli lilly, and america to feature prominently on that list we talked about the weight loss drug companies having extremely high multiples, but the rest of the group has traded at depressed multiples. and i'm thinking of your pfizer. >> pfizer is certainly one of them and it's as if pfizer did nothing before covid and covid vaccines and they're treated as if they didn't and how are they going to come up -- they spent a lot of money they spent $25 billion and put that money to work pretty quickly. and the expectation is, the pipeline that's worth $30 billion in revenues by 2030. we'll see. i do think that pfizer's very interesting here and i do think these negotiations are political and headlines and, you know, it makes some sense they're pushing back, but i'd be amazed if they're able to get some of the victories. i mean the government. >> really? >> i think the drug companies, when they get together and we've

and of course pharma is global. and the u.s. patients and u.s. consumers need the pharma products whether the economy's doing well or not. >> that's fascinating. you guys really do have a r really -- and it's not often you say it's a good thing we're 75% outside of the u.s. what about china? any exposure or secondhand exposure that could tell us what's going on with trends there? >> no, china is an important market for us, for some of our segments like beauty, it's actually the largest beauty market in the world. >> wow. >> and a lot of the sales that we report in europe are really going through global beauty brands like l'oreal or lvmh who then sell their products on to china. clearly their recovery is more muted than people had hoped and expected. but even lower growth on a large base makes a big difference and we have just started up one of our flagship investments in shushz ow, china and we continue to see china as an open market and thankfully we are not in any geopolitically sensitive areas. we're seen as benefiting the chinese patients and

big food gets rich and big pharma richer by treating the obese and unhealthy population.o we fix this? cali means @ true medicofounder and big food whistle blower and joins me now. i mean, it's really a crime to serve lunchables as a lunch to school children and it's actually a bigger crime isn't it while there's profit being met. >> jesse, we're both parents of new young children, and i have to say as pans, we have -- parents, we have to say enough is enough. let's follow the money and go step by step how this happens and we all remember michelle obama talking about healthy school lunches and it was a good policy and she caved. obama's sick tear of state craft and lobbied the obama administration millions and put pressure on michelle obama and stepped away from healthy school lunches and talking about exercise. then kraft and big food paid fda and nutrition and bide lines recommend trying sugar and by food companies and pharma companies and issued millions to people making a nutrition guidelines and those nutrition guidelines inform the school lunch guidelines and trilli

in fact, years ago they got a special carve-out that prohibited drug negotiation, that allowed pharma to charge whatever they can. for decades we've been talking about giving medicare the power to negotiate lower drug prices. president biden actually got it done under the inflation reduction act. finally, medicare will be able to negotiate lower prescription drug costs for seniors and other beneficiaries. this is an historic victory. in fact, over 80% of the public supports giving medicare the power to negotiate lower prescription drug costs. today, as pointed out, the centers for medicare and medicaid services announced the first 10 drugs selected for medicare price negotiation. these 10 drugs are taken by 9 million seniors. they cover chronic conditions like cancer, heart disease, arthritis, and diabetes that can cost up to $14,000 per month. for example, over half a million medicare beneficiaries rely on one of these drugs entreso to treat their heart disease. this drug costs less than $150 in australia and over $300 here u.s.in brevik, one of the selected drugs that treats cancer

purdue pharma filed for bankruptcy in 2019.er the terms of the bankruptcy settlement members of the sackler family would be shielded from future lawsuits in exchange for $6 billion that could be used to settle opioid-related claims. but the justice department says the sacklers should not be able to use legal protections designed for debtors in legal distress. the solicitor general warning, it would leave in place a roadmap for wealthy corporations and individuals to misuse the bankruptcy system. >> what is the issue the supreme court wants to look at? >> the supreme court wants to look at whether people who don't file for bankruptcy like the sam letters that have some connection to a bankruptcy should get the benefit of a release. the bankruptcy court has done that here for the sacklers and the supreme court is deciding whether that violates the law. >> reporter: but for many of the families involved, there is a human toll to further delay. >> i know hundreds of families who have lost. hundreds. and they just want it over. >> p

, purdue pharma, which manufactured oxycontin, was controlled by the sackler family.any before it filed for bankruptcy. the family had agreed to contribute up to $6 billion to produce reorganization funds on one condition. that the family receive a release from civil liability. but the supreme court order means that the settlement payments to victims are now paused and the court will take up the case and hear oral arguments in december. timing, of course, is everything. it just so happens that basically hours ago, netflix produced premiered a new six episode series called painkiller, which takes a semi- fictionalized book about the opioid crisis and how purdue pharma cashed in on oxycontin at the expense of those who became hooked on the drug. >> purdue is a real company bought by you and arthur. people don't understand. >> but you never brought a drug to market, son. takes a decade, and we've got nothing in the pipeline. it is a dead end. >> we know pain. >> that is for sure. >> we developed ms contin. we understand pain. i understand pain. all of human behavior is e

. >>> the supreme court has blocked a massive settlement from going forward for purd ue pharma.en the sackler family, the family behind purdue pharma, broad protection from liability. cnn's senior supreme court analyst has more on this for us. why did the biden administration make this request? and also, what does this move by the supreme court do and say? >> sure. good morning, kate. first of all, this was a settlement that was hammered out by the states and lawyers for victims of the opioid addiction that continues to plague america. but there was a kit condition. and this is what was problematic for the biden administration, that the sackler family, which had controlled purdue pharma, that it would be shielded from any future opioid-related civil court claims. and, in return, the sackler family was going to put up the 6 billion. that's where the settlement stays. and the federal government came in and said we want to challenge the bankruptcy judge's plan here because it exceeds what the bankruptcy code allows. this is what the federal government had said, and wanted the whole

big pharma on alert. >>> it is not just drug prices, washington taking a fresh look at the banking sector. set to propose new rules today. >>> if that weren't enough, lawmakers scheduling a face-to-face meeting with the biggest ceos in d.c. talking a.i. and future red tape. >>> later in the show, a closer look at the i.t. spend slowdown and if there is any highway patrol -- hope for a bounce back. it is tuesday, august 29th, 2023. you are watching "worldwide exchange" here on cnbc. >>> good morning. welcome to "worldwide exchange." i'm hollafrank holland. we kickoff after modest gains yesterday. looking at red across the board. the dow would open up 20 points lower. similar for the nasdaq at this hour. we are checking the bond market. the 10-year treasury is 4.20. it was ten basis points higher the last few days. the 2-year treasury yield is up above 5%. we are looking at the energy ma market. wti crude is back above $80 a barrel. also brent crude is up .50% at $84.83. natural gas market is flat right now. >>> let's see how things are shaping up overseas with julianna tatelbaum. >> great

biden: big pharma is charging americans three times what they charge other countries simply because theyit is outrageous. amy: despite lawsuits from big pharma, the biden administration has announced medicare will begin negotiating to bring down the costs of 10 prescription drugs, including ones

the pharma industry is suing to block the law, claiming it will mean less money for new drugs, and politics should not deck state which treatments and cures are worth developing, and who should get access to them but after capping insulin at $35, polls show broad support for more price caps. >> this is fundamentally about putting prescriptions back in the reach of people, by making them more affordable. >> reporter: pending legal challenges, the new prices on these ten meds should take effect in 2026, then more drug price cuts in '27, '28. 60 drugs over four years. lester >> tom costello, thank you. >>> this week marks two years since the deadly attack during the chaotic withdrawal from afghanistan and today, gold star families who lost loved ones say they are still demanding answers. we get more from ryan nobles >> reporter: two years ago, herman and alicia lopez lost their son, hunter >> it's something that no one thinks will ever happen to their family >> reporter: he was one of 13 u.s. service members killed during the isis bombing near the abbey gate at kabul's airport in afghanistan.

this is the nvidia pharma. what do you do here?idia-like, but i tell you what, they were extraordinary when the bar was very, very high. i have trouble with the valuation. i think this is coming back to earth. >> it's the nvidia pharma, except this time, nvidia is out with a chip that people will get paid to accept >> right >> the importance of this study is that health care will now pay for this drug, because it actually reduces, you know, cardiovascular events. so, that's a game-changer in terms of total addressable market >> think about it. a year ago, we were talking about the prospects of this alzheimer's drug and the stock's rallied 80%. it's a half a trillion dollar market cap and i think i just heard that last year, money jaur roe was $16 million in sales, this year, it's going to be a billion and some of the estimates jared was saying is maybe $100 billion drug. i don't know how you get comfortable, you look at novo and you look at this and they have a combined trillion dollar market cap, i think the valuations are getting

supreme court blocks a $6 billion opioid settlement that would give immunity by the family of purdue pharma, the maker of oxycontin. >>> what happens in vegas, hacking, the white house telling thousands of hackers to try to do their worst against chatgpt. "cnn this morning" starts right now. ♪ >>> the tragedy in hawaii is getting worse by the hour. >> overnight, the increase in the death toll up to now 55, and most people we speak with expect it's going to go even higher. >> and very concerned about a lack of warning that we're hearing from some of the residents there. hawaii's governor says that number of dead likely to increase significantly as search and rescue teams go through hundreds od washington are headed to hawaii now. they will be searching for survivors. they are also bringing cadaver dogs. >> we're getting intel now that the rescue effort is severe. and we want to match that need with what we have. our personnel here are highly trained. they train over the course of several years for this very moment to serve. >> and as poppy mentioned, there are serious questions about if and

there's potential risk when you've got things this expensive. >> what do you think about pharma a bigt have one of these drugs. multiples too high, too low? >> i think it just depends on what you're talking about in pharma you look at word that wah gove have is cutting down there's so much innovation happening in pharma, and the potential for these blockbuster drugs is material. i would rather be kind of the picks and shovels, so west pharmaceuticals that does the direct injector, that's better play for me. >> julie, thank you for joining us this morning. appreciate it. >>> want to take a final check on the markets red arrows across the board, 246 points down on the dow nasdaq, if you can move over for a second there, 106 points off, s&p off about 30 points. the ten-year about 4.0, the two-year at 4.760. melissa, thanks for hanging out this morning. >> i'll be back tomorrow. >> join us tomorrow. "squawk on the street" begins right now. >>> good tuesday morning welcome to "squawk on the street." i'm carl quintanilla with jim cramer and david faber a hefty diet of bearish headlines. moo

there is money that the pharma industry will not get and they are upset about that.ut-of-pocket impact to patients is a little less clear, partly because there are other parts to the policy that affect the patient's pain. alix:. banks, john. appreciate it. that is it for us on this surprisingly optimistic day in the equity markets. can you really trusty price action, though? still a lot of data coming in the next few days. coming up, the grayscale ceo will be joining us and should only invest our -- sonali basak tomorrow at 10:30. coming up, caroline hyde and ed ludlow. this is bloomberg. ♪ i may be known for my legendary football career, but truth is, i love a bunch of sports. the only trouble is knowing where to find them. that's why i got xfinity. so, i can easily find and watch whatever sport i'm into all in one place without missing a thing. even if it's football, australian football, or football football. in a word—it's fitz-credible. i got to trademark that one. this season, eligible xfinity rewards members can get up to $100 off nfl sunday ticket from youtube

big pharma got to get to thee ne root cause. so this is not difficult.jesse, we need to stop recommending this poisonous food. we need to when the usdae ushe is offered millions of dollars by kraft and other big food companies, we need to say no. sug we need the guidelines to say no sugar, no processed food, which flows into the nutritional guidelines for lunchee s. and we need to stop subsidizing it with food stamps, with school luncheh foods, with agriculture subsidies. we are transferring over $100d billion a year from the federal treasury to poisoning our kids.a and if we stop that, wshe capit will unleashal our human capita. we'll save trillions of dollars of downstream health costs , and we'll we'll give our kids a fighting chance, which we're not giving them right now. l >> callie, i love your passion. you're the paul revere of healthf health. and i hope everybody hears this segment and we're going thi to lobby this administration pretty hard on this because as say. poison, as you keep up the good and the solutions are easy. thank you, jesse. all

. >>> and a pause on the purdue pharma settlement. why the supreme court is hitting the brakes on a multibillion dollar bankruptcy deal. >>> good morning, and good to be with you. i'm anne-marie green. we begin with the death toll jumping overnight in the maui wildfires. at least 55 people have died now. and that number is expected to rise. a historic town has all but burned down with more than 1,000 structures destroyed. the fire is 80% contained. search and rescue efforts continue as crews try to reach remote areas of the island. officials expect that it will become the state's deadliest natural disaster in more than six decades. jessica kartalija has more from maui. >> reporter: these are the smoldering ruins of the historic hawaiian city of lahaina. >> we know that many people are suffering, the fatality numbers will climb. >> reporter: hawaii governor josh green toured the devastation yesterday. >> what we saw was likely the largest natural disaster in hawaii state history. >> reporter: local officials say no one could have predi

the quality was not to so big is and about pharma will buy on the market. the sky and all that, and it will sell the cooling the market and the governance of the market price. but when you have the governance of a kind of integration, when you have a partnership govern government has made by partnership where the company offers and gives out or indicates the, the kind of hybrid to the farmer and the farmer knowing that the farmer we'll have more we'll have to take care about the cleaners of the shed. we'll have to take care about the freshness of the demo. bear leaves, palmer. we'll have to wake up at 6 am in the morning and to go to cut the leaves for the day and put it in the warehouse so that they remain fresh all over the day. and uh, and it is a little bit more of a to work more than the uh, than the, the farmer that works with a very strong su, guam that can go there and the at 3 pm and cut the leaves and keep the leaves of the so for him, and he will eat it with that with no problem. very dedicated so warm with the, the that produces a high quality r

whenever you have these kind of integration of pharma, we'll choose those who pays more and then there will be no in the there is no big difference between uh, seen the labor costs for them. if they will, they will get more or less the same price. and there is some difference between the purchasing power of the code in each, in each country. and it is related with the market price more than any other things. but there is no signal significant difference in this in this, in this case, because of farmers, they are not the employees. they are self employed. yeah. they are in the market. thank you so much joe. albert do for all your time today. while the silk industry has provided jobs for hundreds of thousands of people who work along the supply chain, the losers are the so forms were killed after weaving this. so because every cycle, roughly 3000 silkworms are killed to make a single pound of silk, they're usually boiled alive while they're still inside in order to preserve the material quality, thread length, and value. because otherwise, they would chew their way out of their cocoon wh

we are seeing pharma work around it.fizer has done six acquisitions or attempting to do the sixth acquisition in less than two years with seagen. amgen is trying to lock up horizon. a lot of mm&a is taking place sdpplace. >> would you make a decision to hold on to them or buy them? >> we have been in a holding pattern waiting for the top ten since the i.r.a. came out. i feel if the stock dips another 3% to 5% on the headline, i would buy for a trade. i'm not sure much more. >> jared, thanks. it's early. you had to set an alarm for today. >> you bet. sure. >> talk to you later. >>> when we come back, from prescription drugs to the cost of being a caregiver. sharon epperson has a report on the financial and emotional stress of taking care of a loved one. >>> a new report from the japanese news outlet stating toyota will resume operations at the 14 plants starting tomorrow. "squawk box" will be right back. ♪ (upbeat music) ♪ ( ♪♪ ) ( ♪♪ ) ( ♪♪ ) -awww. -awww. -awww. -nope. ( ♪♪ ) constant contact delivers the marketing tool

the quality was not to so big is and about pharma will buy on the market, the sky and all that. and it will sell the cooling the market and the governance of the market price. but when you have the governance of a kind of integration, when you have a partnership govern government has made by the partnership where the company offers and gives out or indicates the kind of a hybrid to the farmer and the farmer. knowing that the farmer will have more will have to take care about the cleaners of the shed will have to take care about the freshness of the demo. bear leaves, palmer will have to wake up at 6 am in the morning and to go to cut the leaves uh for the day and put it in the warehouse so that they remain fresh all over the day. and then it is a little bit more of a to work more than the uh, than the, the farmer that works with a very strong assume guam that can cause to go there and the at 3 pm and cut the leaves and give the leaves to the so for him and he will eat it with that with no problem. very dedicated to warm with uh, the that produces a high quality russell that will

it has also been an international headlines with a high number of pharma suicides that happen too long dry spells are often a direct cause for economic distress. but for one community here, switching to a drought resistance crops, what ip has made all the difference? these concludes phones as a preaching spots of light spun from a 900 metre long silk thread. the 2 precious they provide chief at euro cut off with an income such a welcome new development. i'm gonna have to make no money with cost and today i'm only about a $100000.00 rupees a month to look. i know there was still some clerical fields even though that's why the roster is traditional cotton grabbing region. but climate change is taking its toll with increasingly long periods of drought followed by heavy rains which destroy the hobbies and threatened livelihood. as a result, the highest suicide rate among farm is in the last 6 months of 2022 desperation led more than a 1000 farm is in my roster to take their own lives. the village is really the hindi wood for cotton is also affected by climate change. in the past, everyone

. >> today big pharma doesn't just get a big check. >> in 2003, the republican congress banned medicare from negotiating lower drug prices. the new law empowers medicare to do just that, negotiate. if drug companies don't participate, they face tax penalties. the pharma industry is suing to block the law, claiming it will mean less money for new drugs, and politics should not dictate which treatments and cures are worth developing and who should get access to them. but after capping insulin at $35, polls show broad support for more price caps. >> this is fundamentally about putting prescriptions back in the reach of people by making them more affordable. >> reporter: pending legal challenges, the new prices on these 10 meds should take effect in 2026. then more drug cuts in '27, '28. 60 drugs over four years. lester? >> tom costello, thank you. >>> this week marks two years since the deadly attack during the chaotic withdrawal from afghanistan. and today gold star families who lost loved ones say they are still demanding answers. we get more from ryan nobles. >> reporter: two years ago,

out with 2 silk them, eggs this from not they've got 200 kilos of so good coons exploit when the pharma salt is part of the for a 120000 rupees. he couldn't believe it. he'd never made that kind of money from 10 acres of company funding was for boy, just 2 acres of siri culture. yeah. and a lot of money for people. that's how it started, of this, sorry coat to model that really soon started to cut shown in the light and region. a growing number of from is a now planting mulberry trees, which a category showed to improves the harvest. the leaves provide food for the so when the moby trees a holiday, they grow for several years. i'm inclined much less school to fund makes the my deal for this drought stricken region. according to kind of coach experts seem a how to she works closely with the farmers in myra hosta. instead of capturing you've gone keels best as i phone in you. i'm going to be renovations, so that isn't everything data because you know, so you learn more about is seeing there is all of a flaw. the danger and then uh uh, in, in getting that doesn't, doesn't, does. she's off

kate anyway, coming up, big pharma too big up, does big pharma have too big a and our is too quick to we'll prescribe medicines? we'll be speaking doctor lloyd speaking to doctor david lloyd and shortly. and davinia taylor shortly. you're watching gb news, the people's channel. >> a brighter outlook with boxt solar proud sponsors of weather on . gb news. hello solar proud sponsors of weather on. gb news. hello i'm solar proud sponsors of weather on . gb news. hello i'm marco petagna. >> here's your latest weather update from the met office. we'll see a mixed bag of weather across the uk today. a mixture of sunny spells, some showers and feeling cool in a fairly brisk south westerly breeze. two low pressures anchored towards the and it the north—west of the uk and it sees fairly tightly packed isobars, those fairly isobars, giving those fairly breezy with showers breezy conditions with showers moving the west and moving in from the west and southwest. certainly a southwest. but certainly quite a few contend with as few showers to contend with as we through the afternoon we go through t

when one family member got the pharma gangs involved, luckily they cooled the blanket people even really was that at that time on the holy a minimum. when was that a high about how about we knew here now? which means give up to what type gala momma for me and really is sending a news releasing is normal. now i our drive our comes out at the moment. are you going to more every get our own people come to new, go come on and grades and here you go to the board to yes, it is code on come on writing for to me about i was about to run about among not believe it was ever really it was a but it is by full. yeah. i've resented off around a couple for now $140.00 k. now what i want, i didn't want to clarify when i was doing the car or or good. what to do with the chief trouble climate and his daughter in law now suffer from post traumatic stress. well, that is true with that one that i would never hold on to the recovery we part where we puzzled. i'm ready to wonder about generally go home lawyer to be more. no, no, no, hold on. that's a whole. another adult dilemma. oh no. so. so if i'm a mess th

. ♪ amna: the supreme court has temporarily blocked a bankruptcy plan for drug maker purdue pharma -- would've paid out billions of dollars to address the opioid epidemic, but would have also shielded the company's owners -- the sackler family -- from legal liability. william brangham has more on the implications. william: amna, this controversial bankruptcy plan was stalled because the u.s. justice department argued that shielding the sacklers from all future lawsuits was an abuse of the bankruptcy system. the sacklers themselves did not declare bankruptcy. but that delay means that at least six billion dollars in relief is not going to communities all over the country to help them address the addiction and overdose crisis. npr's brian mann has been covering all of this closely. he joins us now. welcome back. we thought this was a settled issue, several judges have signed off on this. help us understand, what happened at the supreme court yesterday? brian: it surprised a lot of legal experts that the supreme court was willing to take this on. in the past, the supreme court has been r